Literature DB >> 7669898

Characterization of a folding intermediate of human carbonic anhydrase II: probing local mobility by electron paramagnetic resonance.

M Lindgren1, M Svensson, P O Freskgård, U Carlsson, P Jonasson, L G Mårtensson, B H Jonsson.   

Abstract

The spin-labeling method was used to investigate human carbonic anhydrase, HCA II, undergoing unfolding induced by guanidine-HCI (Gu-HCI). The spin-probe, N-(2,2,5,5-tetramethyl-1-yloxypyrrolidinyl-3-yl)iodoacetamide, was attached covalently to the single cysteine (position 206) in the enzyme. The electron paramagnetic resonance spectrum of the folded structure showed the characteristic slow motional spectra. When the concentration of the denaturing agent, Gu-HCI, was gradually increased, new spectral components with narrower lines evolved to give complex electron paramagnetic resonance spectra, apparently containing superimposed contributions from several components of different mobility. By a differentiation technique, it was possible to follow the relative increase of the narrow components as a function of Gu-HCI concentration. The amplitude of difference spectra versus Gu-HCI concentration showed two distinct maxima, indicating the existence of a folding intermediate state/structure. The results were found to agree with optical absorption data, which showed similar transitions at the same Gu-HCI concentrations. From line-shape simulations assuming a Brownian diffusion model, the rotational diffusion constants for the spin-label in the folded, folding intermediate, and unfolded structures were determined. The relative abundances of the three conformations in the region 0-4 M Gu-HCI were obtained by least squares fitting of the simulated spectra to the experimental ones. The folding intermediate was found to have a maximum population of 39 +/- 4% at approximately 0.7 M Gu-HCI.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7669898      PMCID: PMC1236238          DOI: 10.1016/S0006-3495(95)79892-7

Source DB:  PubMed          Journal:  Biophys J        ISSN: 0006-3495            Impact factor:   4.033


  15 in total

Review 1.  Selective placement of electron spin resonance spin labels: new structural methods for peptides and proteins.

Authors:  G L Millhauser
Journal:  Trends Biochem Sci       Date:  1992-11       Impact factor: 13.807

2.  Paramagnetic and fluorescent probes attached to "buried" sulfhydryl groups in human carbonic anhydrases. Application to inhibitor binding, denaturation and refolding.

Authors:  U Carlsson; R Aasa; L E Henderson; B H Jonsson; S Lindskog
Journal:  Eur J Biochem       Date:  1975-03-03

3.  Structural studies on transmembrane proteins. 2. Spin labeling of bacteriorhodopsin mutants at unique cysteines.

Authors:  C Altenbach; S L Flitsch; H G Khorana; W L Hubbell
Journal:  Biochemistry       Date:  1989-09-19       Impact factor: 3.162

4.  Site-directed mutagenesis of colicin E1 provides specific attachment sites for spin labels whose spectra are sensitive to local conformation.

Authors:  A P Todd; J Cong; F Levinthal; C Levinthal; W L Hubbell
Journal:  Proteins       Date:  1989

5.  Detection and characterization using circular dichroism and fluorescence spectroscopy of a stable intermediate conformation formed in the denaturation of bovine carbonic anhydrase with guanidinium chloride.

Authors:  R W Henkens; B B Kitchell; S C Lottich; P J Stein; T J Williams
Journal:  Biochemistry       Date:  1982-11-09       Impact factor: 3.162

6.  Role of an evolutionarily invariant serine for the stability of human carbonic anhydrase II.

Authors:  L G Mårtensson; B H Jonsson; M Andersson; A Kihlgren; N Bergenhem; U Carlsson
Journal:  Biochim Biophys Acta       Date:  1992-01-09

7.  Refined structure of human carbonic anhydrase II at 2.0 A resolution.

Authors:  A E Eriksson; T A Jones; A Liljas
Journal:  Proteins       Date:  1988

8.  Altering the mouth of a hydrophobic pocket. Structure and kinetics of human carbonic anhydrase II mutants at residue Val-121.

Authors:  S K Nair; T L Calderone; D W Christianson; C A Fierke
Journal:  J Biol Chem       Date:  1991-09-15       Impact factor: 5.157

9.  Contribution of individual tryptophan residues to the fluorescence spectrum of native and denatured forms of human carbonic anhydrase II.

Authors:  L G Mårtensson; P Jonasson; P O Freskgård; M Svensson; U Carlsson; B H Jonsson
Journal:  Biochemistry       Date:  1995-01-24       Impact factor: 3.162

10.  Evidence for an initial fast nucleation process in the folding of human carbonic anhydrase I.

Authors:  N Bergenhem; U Carlsson; J A Karlsson
Journal:  Int J Pept Protein Res       Date:  1989-02
View more
  5 in total

1.  Properties of spin and fluorescent labels at a receptor-ligand interface.

Authors:  R Owenius; M Osterlund; M Lindgren; M Svensson; O H Olsen; E Persson; P O Freskgård; U Carlsson
Journal:  Biophys J       Date:  1999-10       Impact factor: 4.033

2.  Structural Characterization of Native Proteins and Protein Complexes by Electron Ionization Dissociation-Mass Spectrometry.

Authors:  Huilin Li; Yuewei Sheng; William McGee; Michael Cammarata; Dustin Holden; Joseph A Loo
Journal:  Anal Chem       Date:  2017-02-22       Impact factor: 6.986

3.  High-resolution probing of local conformational changes in proteins by the use of multiple labeling: unfolding and self-assembly of human carbonic anhydrase II monitored by spin, fluorescent, and chemical reactivity probes.

Authors:  P Hammarström; R Owenius; L G Mårtensson; U Carlsson; M Lindgren
Journal:  Biophys J       Date:  2001-06       Impact factor: 4.033

4.  Sequential assignment of 1H, 13C and 15N resonances of human carbonic anhydrase I by triple-resonance NMR techniques and extensive amino acid-specific 15N-labeling.

Authors:  I Sethson; U Edlund; T A Holak; A Ross; B H Jonsson
Journal:  J Biomol NMR       Date:  1996-12       Impact factor: 2.835

5.  Accessing local structural disruption of Bid protein during thermal denaturation by absorption-mode ESR spectroscopy.

Authors:  Chien-Lun Hung; Yu-Ying Lin; Hsin-Ho Chang; Yun-Wei Chiang
Journal:  RSC Adv       Date:  2018-10-09       Impact factor: 3.361

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.